WHA22.50  Quality  Control  of Drugs 
The Twenty-second  World  Health  Assembly, 
Recalling  resolution  WHA21.37; 
Having  considered  the  report  of the Director-General  on the quality  control  of drugs; 
Noting  with  satisfaction  the formulation  of the “ Principles  of Pharmaceutical  Quality  Control，，1  and 
“ Good  Practices  in the  Manufacture  and  Quality  Control  of Drugs，，2  as presented  in the  report  of the 
Director-General  ； 
Recognizing  that  general  observance  of such  principles  and  practices  is essential  and,  in particular,  a 
prerequisite  for a system  of certification  for drugs  in international  commerce;  and 
Considering  that  general  acceptance  of such  a certification  system  would  be an important  first  step 
toward  ensuring  the desired  level  of quality  control  of drugs  in international  commerce, 
1. RECOMMENDS  that  Member  States  adopt  and  apply 
(1) the  requirements  for  “ Good  Practices  in the  Manufacture  and  Quality  Control  of Drugs  ” as 
formulated  in the report  of the Director-General,2 
(2) the  certification  scheme  on the quality  of pharmaceutical  products  moving  in international  commerce 
as formulated  in the  report  of the  Director-General  as amended.3 
2. REQUESTS  the Director-General  to report  to the Twenty-third  World  Health  Assembly 
(1) on  those  improvements  in the requirements  for good  manufacturing  practice  and  in the certification 
scheme  which  may  appear  to be necessary  ； and 
(2) on  further  progress  with  regard  to the certification  scheme  and  the implementation  thereof. 
Handb.  Res.,  10th  ed.，1.10.4.1  Fourteenth  plenary  meeting,  25 July  1969  (Committee 
on Programme  and  Budget,  sixth  report) 
